Revenue grew 5.8% year-over-year in H1 2026, with adjusted EBITDA up 17.8% and net income up 30.6%. The professional division led growth, while the group raised its full-year EBITDA guidance to €670–€690 million amid ongoing macroeconomic uncertainty.Original document: De'Longhi S.p.A. [DLG] Earnin…
Second quarter 2026 revenue grew 4.9% to $2.6 billion, with net income of $223 million and EPS of $0.48, both above guidance. Cost controls and strategic initiatives delivered $100 million in annualized savings, but demand remains pressured, especially at the Norwegian brand.Original document: Norw…
RNS Number : 6016O International Paper Company 30 July 2026 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTIONTHIS ANNOUN…
Second quarter revenue grew 2% year-over-year to $1.31 billion, with adjusted free cash flow up 48% to $406 million and adjusted EPS flat at $0.23. The company launched new AI-driven and self-install products, returned $684 million to shareholders, and updated its 2026 outlook to reflect continued…
Q2 2026 saw net income surge to $387.3 million and net sales rise 16% year-over-year, with strong EBITDA growth and significant debt reduction. Segment performance was robust, and management projects continued earnings growth and lower leverage into 2027.Original document: Darling Ingredients Inc…
Q2 2026 saw a dramatic turnaround with income from operations and net income surging year-over-year, driven by higher refining margins, Martinez refinery restart, and substantial insurance recoveries. Over $1 billion in debt was repaid, and the dividend was maintained at $0.275 per share.Original d…
Q2 2026 revenue rose 13% year-over-year to $568 million, with both segments delivering double-digit growth and margin expansion. Full-year guidance was raised, and $161 million was returned to shareholders year-to-date. Adjusted EBITDA margin held at 19.8%.Original document: Ralliant Corporation [R…
Net income and revenues surged year-over-year, driven by strong performance across all segments and higher product margins. Cash returns to stockholders were robust, and the company maintained a strong balance sheet while advancing key projects.Original document: Valero Energy Corporation [VLO] SEC…
Q2 2026 saw record revenue of $1.1 billion and net income up nearly 50% year-over-year, driven by strong box office performance and operational optimization. Adjusted EBITDA reached an all-time high, with robust cash flow and continued market share gains.Original document: Cinemark Holdings, Inc…
Record Q2 2026 revenue grew 39% year-over-year to $32.6 million, with gross margin up to 71.4%. Adjusted EBITDA loss improved 78% to $1.4 million, and full-year guidance was raised. U.S. revenue surged, while international sales declined, offset by new market entry in Brazil.Original document: Butt…
Q2 2026 revenues grew 1% year-over-year to $674 million, with security subscriptions up 12%. Non-GAAP EPS rose 8% to $2.55, and cash balances reached $4.2 billion, aided by a convertible notes offering. Share repurchases and R&D tax incentives supported capital allocation.Original document: Check P…
Q2 2026 saw 11% revenue growth to $180M, with net loss narrowing to $2.5M and Adjusted EBITDA at $23.8M. Issuance of $115M in convertible notes and a major share repurchase enhanced financial flexibility. Full-year guidance is unchanged, with strong Canadian growth expected.Original document: Civeo…
Record H1-2026 results featured $761m free cash flow and $301m shareholder returns, with production and financials on track for FY-2026 guidance. Major growth projects and exploration are progressing, and liquidity remains strong despite higher costs from elevated gold prices.Original document: End…
Record Q1 sales and orders were driven by the Kito Crosby Acquisition, with adjusted EBITDA margin up 720 bps year-over-year. FY27 guidance was raised for net sales, adjusted EBITDA, and EPS, reflecting strong demand and synergy realization.Original document: Columbus McKinnon Corporation [CMCO] SE…
Q2 2026 revenues rose 17% to $4.3B, led by record sales of Dupixent, EYLEA HD, and Libtayo. Non-GAAP EPS grew 11% to $14.29, and the Sanofi Development Balance was fully repaid, boosting future collaboration profits. Regulatory and pipeline progress continued.Original document: Regeneron Pharmaceut…
Q2 2026 saw 7% revenue growth, significant margin expansion, and strong cash flow, driven by demand for connected devices and SaaS. Full-year guidance was raised for non-GAAP EBITDA and EPS, with leadership changes to support long-term growth.Original document: Omnicell, Inc. [OMCL] SEC 8-K Current…
Standalone and consolidated Q1 FY27 results showed strong revenue and profit growth sequentially, with improved margins and robust segment performance. Results were influenced by government subsidy policies and a joint venture loss impacted consolidated profit.Original document: Chambal Fertilisers…
Revenue and EBITDA each grew 9% year-over-year in H1 2026, with net profit up 157% and a 122% increase in cash dividend. The concession portfolio valuation rose 16% to €4.601 billion, and the backlog reached €73.3 billion, supporting continued growth and strong cash generation.Based on Sacyr SA [SC…
Q2 2026 saw sequential revenue and profit growth, with net income rising to $12.1 million and Adjusted EBITDA to $66.0 million. Technical Services and Support Services segments both improved, and a regular dividend was declared. Leadership transition and ongoing M&A shape the outlook.Original docum…
Q2 2026 saw a net loss of $42.1 million due to a one-time $68.8 million credit expense from a single BaaS partner, offsetting record net interest income and strong BaaS growth. Core capital and liquidity remain robust, and management expects continued BaaS expansion and disciplined growth.Original…
